InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
2
T+90 hit rate
25%
T+90 mean return
-7.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hayden Michael R, Director. Insider active across 5 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 18 disclosures have been published. Breakdown: 5 buys · 2 sells. Total volume traded: €5.1m. Activity tracked since 18 May 2021. The latest transaction was disclosed on 1 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
15,000 shares@ US$31.8683.0% of flowCommon StockSEC:0000874015-25-000125:0
Ideal exit: 26 Jan 2026 (T+270)
2,500 shares@ US$36.198317.0% of flowCommon StockSEC:0000874015-24-000243:0
Ideal exit: 19 Sept 2025 (T+270)
20,000 shares@ US$4.910.7% of flowCommon SharesSEC:0001703057-23-000032:0
Ideal exit: 18 Jun 2024 (T+270)
30,000 shares@ US$5.901.3% of flowCommon SharesSEC:0001703057-23-000024:0
Ideal exit: 4 May 2024 (T+270)
1,777 shares0Common StockSEC:0000874015-23-000174:0
6,250 shares@ US$3.62100.0% of flowCommon StockSEC:0000950170-23-010969:0
Ideal exit: 25 Dec 2022 (T+270)
1,777 shares0Common StockSEC:0000874015-22-000165:0
5,333 shares0Common StockSEC:0000874015-22-000138:0
1,777 shares0Common StockSEC:0000874015-21-000162:0
1,777 shares0Common StockSEC:0000874015-21-000162
270,000 shares@ US$17.730.32% mcap32.7% of flowCommon SharesSEC:0001209191-21-056163:0
270,000 shares@ US$17.7332.1% of flowCommon SharesSEC:0001209191-21-056163
5,333 shares0Common StockSEC:0000874015-21-000134
5,333 shares0Common StockSEC:0000874015-21-000134:0
100,000 shares@ US$25.5016.9% of flowCommon SharesSEC:0000899243-21-025366
100,000 shares@ US$25.500.17% mcap17.3% of flowCommon SharesSEC:0000899243-21-025366:0
3,500 shares@ US$3.850.0002% mcap100.0% of flowCommon SharesSEC:0001209191-21-034396:0
3,500 shares@ US$3.85100.0% of flowCommon SharesSEC:0001209191-21-034396
18 of 18 declarations
About Hayden Michael R
Michael R. Hayden is a Board Member at Xenon Pharmaceuticals Inc. and AbCellera Biologics Inc. He contributes to the governance of these companies, providing his expertise to guide strategic decisions and ensure compliance with industry standards.
